InsiderClue
Insiders · Profile

Atlas Venture Fund XI, L.P.

10% owner at Sionna Therapeutics · 10% owner at Dyne Therapeutics · 10% owner at Xilio Therapeutics · and 1 more. Filing since 30 Mar 2021. CIK 0001708269

SION Sionna Therapeutics, Inc. 10% owner · 1 trade DYN Dyne Therapeutics, Inc. 10% owner · 13 trades XLO Xilio Therapeutics, Inc. 10% owner · 7 trades IMA ImageneBio, Inc. 10% owner · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
SION Sionna Therapeutics, Inc.
10 Feb 2025
10% owner
Bought
60,000
$1.08M
8.0%
DYN Dyne Therapeutics, Inc.
28 Feb 2024
10% owner
Sold on a plan
154,674
$3.84M
2.6%
DYN Dyne Therapeutics, Inc.
28 Feb 2024
10% owner
Sold on a plan
36,246
$900.23K
4.0%
DYN Dyne Therapeutics, Inc.
27 Feb 2024
10% owner
Sold on a plan
298,702
$7.29M
4.9%
DYN Dyne Therapeutics, Inc.
27 Feb 2024
10% owner
Sold on a plan
69,997
$1.71M
7.4%
DYN Dyne Therapeutics, Inc.
26 Feb 2024
10% owner
Sold on a plan
201,095
$4.77M
3.2%
DYN Dyne Therapeutics, Inc.
26 Feb 2024
10% owner
Sold on a plan
47,124
$1.12M
5.0%
DYN Dyne Therapeutics, Inc.
23 Feb 2024
10% owner
Sold on a plan
159,542
$3.62M
2.4%
DYN Dyne Therapeutics, Inc.
23 Feb 2024
10% owner
Sold on a plan
37,386
$848.66K
3.9%
DYN Dyne Therapeutics, Inc.
22 Feb 2024
10% owner
Sold on a plan
119,360
$2.70M
1.8%
DYN Dyne Therapeutics, Inc.
21 Feb 2024
10% owner
Sold on a plan
184,501
$4.16M
2.7%
DYN Dyne Therapeutics, Inc.
20 Feb 2024
10% owner
Sold on a plan
169,539
$3.85M
2.4%
DYN Dyne Therapeutics, Inc.
16 Feb 2024
10% owner
Sold on a plan
162,707
$3.77M
2.3%
DYN Dyne Therapeutics, Inc.
15 Feb 2024
10% owner
Sold on a plan
177,906
$4.25M
2.4%
XLO Xilio Therapeutics, Inc.
8 Feb 2024
10% owner
Sold at will
733
$469.12
0.0%
XLO Xilio Therapeutics, Inc.
8 Feb 2024
10% owner
Sold at will
267
$170.88
0.0%
XLO Xilio Therapeutics, Inc.
12 Jan 2024
10% owner
Sold at will
1,540
$1.28K
0.1%
XLO Xilio Therapeutics, Inc.
12 Jan 2024
10% owner
Sold at will
560
$464.80
0.1%
XLO Xilio Therapeutics, Inc.
11 Jan 2024
10% owner
Sold at will
1,566
$1.36K
0.1%
XLO Xilio Therapeutics, Inc.
11 Jan 2024
10% owner
Sold at will
569
$495.03
0.1%
IMA ImageneBio, Inc.
14 Dec 2021
10% owner
Sold, plan not stated
5,959
$83.43K
0.5%
IMA ImageneBio, Inc.
13 Dec 2021
10% owner
Sold, plan not stated
8,330
$121.95K
0.7%
IMA ImageneBio, Inc.
10 Dec 2021
10% owner
Sold, plan not stated
11,989
$180.19K
0.9%
XLO Xilio Therapeutics, Inc.
26 Oct 2021
10% owner
Bought
187,500
$3.00M
34.2%
IMA ImageneBio, Inc.
30 Mar 2021
10% owner
Bought
125,000
$2.00M
16.7%
25 decisions on file.